The Melody Transcatheter Pulmonary Valve(Tpv), approved in Europe in 2006 and in the U.S. in 2010 under a Humanitarian Device Exemption(HDE),
is designed to treat congenital heart disease patients with a dysfunctional conduit in their right ventricular outflow tract RVOT.